Eagle Asset Management Inc Pfizer Inc Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Asset Management Inc holds 668,520 shares of PFE stock, worth $17.6 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
668,520
Previous 664,275 0.64%
Holding current value
$17.6 Million
Previous $18.6 Million 4.09%
% of portfolio
0.12%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$27.7 - $31.39 $117,586 - $133,250
4,245 Added 0.64%
668,520 $19.3 Million
Q2 2024

Aug 12, 2024
BUY
$25.26 - $29.6 $3.69 Million - $4.32 Million
146,077 Added 28.19%
664,275 $18.6 Million
Q1 2024

May 09, 2024
BUY
$25.89 - $29.73 $10.5 Million - $12 Million
404,725 Added 356.67%
518,198 $14.4 Million
Q4 2023

Feb 12, 2024
BUY
$26.13 - $33.94 $2,194 - $2,850
84 Added 0.07%
113,473 $3.27 Million
Q3 2023

Nov 13, 2023
BUY
$32.09 - $37.51 $320 - $375
10 Added 0.01%
113,389 $3.76 Million
Q2 2023

Aug 09, 2023
SELL
$36.12 - $41.79 $4.45 Million - $5.14 Million
-123,089 Reduced 52.05%
113,379 $4.16 Million
Q1 2023

May 08, 2023
BUY
$39.39 - $51.28 $4.45 Million - $5.8 Million
113,030 Added 91.57%
236,468 $9.65 Million
Q4 2022

Feb 14, 2023
SELL
$41.75 - $54.5 $140,906 - $183,937
-3,375 Reduced 2.66%
123,438 $6.33 Million
Q3 2022

Nov 07, 2022
BUY
$43.76 - $53.42 $1.06 Million - $1.29 Million
24,217 Added 23.6%
126,813 $5.55 Million
Q2 2022

Aug 10, 2022
BUY
$46.53 - $55.17 $1.27 Million - $1.51 Million
27,299 Added 36.26%
102,596 $5.38 Million
Q1 2022

May 12, 2022
BUY
$45.75 - $56.69 $3.44 Million - $4.27 Million
75,297 New
75,297 $3.9 Million
Q3 2021

Nov 10, 2021
SELL
$39.25 - $50.42 $8.4 Million - $10.8 Million
-213,966 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$35.91 - $40.68 $1.41 Million - $1.6 Million
39,354 Added 22.54%
213,966 $8.38 Million
Q1 2021

May 14, 2021
SELL
$33.49 - $37.77 $959,421 - $1.08 Million
-28,648 Reduced 14.09%
174,612 $6.34 Million
Q4 2020

Feb 12, 2021
SELL
$33.47 - $42.56 $89.7 Million - $114 Million
-2,678,834 Reduced 92.95%
203,260 $7.48 Million
Q3 2020

Nov 12, 2020
SELL
$31.75 - $37.25 $23.3 Million - $27.4 Million
-734,403 Reduced 20.31%
2,882,094 $104 Million
Q2 2020

Aug 12, 2020
SELL
$30.12 - $36.54 $1.14 Million - $1.39 Million
-37,972 Reduced 1.04%
3,616,497 $118 Million
Q1 2020

May 11, 2020
SELL
$27.03 - $38.62 $7.25 Million - $10.4 Million
-268,040 Reduced 6.83%
3,654,469 $119 Million
Q4 2019

Feb 07, 2020
BUY
$32.92 - $37.36 $3.48 Million - $3.94 Million
105,574 Added 2.77%
3,922,509 $154 Million
Q3 2019

Nov 04, 2019
BUY
$32.49 - $42.13 $56.9 Million - $73.8 Million
1,752,551 Added 84.89%
3,816,935 $137 Million
Q2 2019

Aug 05, 2019
BUY
$36.98 - $41.52 $4.52 Million - $5.08 Million
122,272 Added 6.3%
2,064,384 $89.4 Million
Q1 2019

May 01, 2019
SELL
$37.5 - $41.2 $18.6 Million - $20.4 Million
-495,416 Reduced 20.32%
1,942,112 $82.5 Million
Q4 2018

Feb 11, 2019
SELL
$38.47 - $43.86 $11.6 Million - $13.3 Million
-302,742 Reduced 11.05%
2,437,528 $106 Million
Q3 2018

Nov 08, 2018
SELL
$34.47 - $41.81 $23.5 Million - $28.5 Million
-682,041 Reduced 19.93%
2,740,270 $121 Million
Q2 2018

Aug 07, 2018
SELL
$32.98 - $35.16 $193,988 - $206,811
-5,882 Reduced 0.17%
3,422,311 $124 Million
Q1 2018

May 09, 2018
SELL
$31.91 - $37.02 $76,871 - $89,181
-2,409 Reduced 0.07%
3,428,193 $122 Million
Q4 2017

Feb 09, 2018
BUY
$33.26 - $35.29 $708,205 - $751,429
21,293 Added 0.62%
3,430,602 $122 Million
Q3 2017

Nov 09, 2017
BUY
$31.0 - $34.15 $106 Million - $116 Million
3,409,309
3,409,309 $123 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.61B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email